Companies: 10,795·Total market cap: $144.5T
BioVaxys Technology Corp.

BioVaxys Technology Corp.

BVAXFOTCHealthcare● Active
$0.11
$-0.07(-39.61%)
Market Cap$3151385
P/E Ratio—
52W High$0.3
52W Low$0.0209
PE RatioMarket CapForecast

BioVaxys Technology Corp. (BVAXF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

bvaxf · pe ratio · data through Jun 9, 2026

Core PE Ratio Metrics

Trailing 12 months · TTM

Insufficient PE history data (fewer than 3 valid fiscal years).

PE Ratio vs Peers

Biotechnology · 5 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
BioVaxys Technology Corp.
BioVaxys Technology Corp.You
BVAXF
$3MN/A——
Bioxytran, Inc.
Bioxytran, Inc.
BIXT
$3MN/A—-$0.02
Burzynski Research Institute, Inc.
Burzynski Research Institute, Inc.
BZYR
$1MN/A—-$0.01
Curative Biotechnology, Inc.
Curative Biotechnology, Inc.
CUBT
$11MN/A—-$0.00
Futura Medical plc
Futura Medical plc
FAMDF
$1MN/A—-$0.03
Kane Biotech Inc.
Kane Biotech Inc.
KNBIF
$4MN/A—-$0.02

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for BioVaxys Technology Corp. (BVAXF) measures how much investors pay for each dollar of the company's trailing earnings. BVAXF's current PE ratio of N/A is calculated by dividing its stock price of $0.11 by its TTM earnings per share of —.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.11 ÷ — = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.
Price historyFinancial statementsEarnings

Frequently asked questions

BVAXF pe ratio · 6 questions

BVAXF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.11 and TTM EPS of —. Data sourced from Financial Modeling Prep via BVAXF's SEC 10-K and 10-Q filings.

BVAXF PE ratioWhat is BVAXF PE ratioCurrent PE ratio of BVAXFBVAXF PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioVaxys Technology Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09